Ketamine may block NMDA receptors in astrocytes causing a rapid antidepressant effect by Bernhard J. Mitterauer
OPINION ARTICLE
published: 24 December 2012
doi: 10.3389/fnsyn.2012.00008
Ketamine may block NMDA receptors in astrocytes causing
a rapid antidepressant effect
Bernhard J. Mitterauer*
Volitronics-Institute for Basic Research, Psychopathology and Brain Philosophy, University of Salzburg, Salzburg, Austria
*Correspondence: bernhard.mitterauer@sbg.ac.at
Edited by:
Dirk Feldmeyer, RWTH Aachen University, Germany
Reviewed by:
Sheriar Hormuzdi, University of Dundee, UK
Filippo Tempia, University of Turin, Italy
Marlene Bartos, University of Freiburg, Germany
Depression is associated both with a
reduced size of brain regions regulating
mood and cognition, including the pre-
frontal cortex and the hippocampus, and
decreased neuronal synapses in these areas.
Antidepressants can block or reverse these
neuronal deficits although they have lim-
ited efficacy and delayed response time
of weeks or months. Basic studies show
that ketamine, an N-methyl-D-asparate
(NMDA) receptor antagonist, produces
rapid (within hours) antidepressant effects
in patients with chronic depression who
are resistant to typical antidepressants
(Zarate et al., 2006; Machado-Vieira et al.,
2012). The rapid antidepressant actions of
ketamine could involve a number of cor-
tical and limbic brain regions, many of
which are reported to show alterations of
glutamate transmission and synaptic activ-
ity (Li et al., 2010). There is experimental
evidence that ketamine induces synaptoge-
nesis leading to the synaptogenic hypoth-
esis of depression and treatment response
(Duman and Aghajanian, 2012).
Ketamine rapidly reverses the deficit
in spine density, as well as the anhe-
donia and anxiety caused by exposure
to chronic stress. However, the mecha-
nisms underlying this action of ketamine,
an NMDA antagonist, is as yet not fully
understood (Diazgranados et al., 2010).
Li et al. (2010) observed that ketamine
rapidly activated the mammalian target
of rapamacin (mTOR) pathway, leading
to increased synaptic signaling proteins
and increased number and function of
new spine synapses in the prefrontal cor-
tex of rats. Importantly, these researchers
admit that the mechanisms underlying
rapid antidepressant actions have not been
identified so far and that they are likely
more complicated than simple NMDA
receptor blockade. According to Duman
and Aghajanian (2012), the discovery that
ketamine rapidly increases the number
and function of synaptic connections has
focused attention on synaptogenesis as a
fundamental process for the treatment of
depressive symptoms, and it also suggests
that disruption of synaptogenesis and loss
of connections underlies the pathophysiol-
ogy of depression.
In addition, we should also refer to
glial-neuronal synaptic units. First of all,
perisynaptic astrocytes (glial cells) play a
role in promoting the stabilization and
maturation of dendritic spines (Stevens,
2008). Life imaging experiments indicate
that astrocytes show striking morpholog-
ical plasticity at the synapse. Time-lapse
confocal imaging of dendritic spines and
astrocytes in acute slices from trans-
genic mice revealed that astrocytes rapidly
extend and retract filopodia-like processes
within a time-scale of minutes (Hirrlinger
et al., 2004). Hence, this modulatory
function of astrocytes in synaptogenesis
has been ignored in the current model
of the pathophysiology of depression.
There is clear spatiotemporal correlation
between the onset of synaptogenesis and
the appearance and association of imma-
ture astrocytes with neurons at central
nervous system synapses (Ullian et al.,
2004), suggesting that astrocytes may
provide instructive signals to control the
formation and development of synapses.
Experimental findings indicate that astro-
cytes have a powerful ability to promote
excitatory and inhibitory synaptogenesis
(Hu et al., 2007; Stevens, 2008). Moreover,
astrocytes exert a modulatory function
of neurotransmission in glial-neuronal
synaptic units, also called tripartite
synapses (Haydon andCarmignoto, 2006).
Given the fact that glial-neuronal synaptic
units are experimentally well established,
we are faced with the question of the
role of astrocytes in the pathophysiol-
ogy of depression. I have hypothesized
(Mitterauer, 2009, 2010a,b) that in depres-
sion an astrocytic syncytiopathy (glial
network disorder)—caused by a down-
regulation of connexins (proteins of gap
junctions)—may lead to an upregulation
of astrocytic receptors (Rouach et al., 2002;
Suadicani et al., 2003). Such an excess of
astrocytic receptors exerts a relative lack
of neurotransmitters such that the synap-
tic information processing is imbalanced.
It has been experimentally verified that
astrocytes express all receptors for the
occupancy with the cognate neurotrans-
mitter types (Hansson and Rönnbäck,
2004). This holds also for NMDA recep-
tors. There is definitive experimental
evidence for the existence of functional
NMDA receptor expression in human
astrocytes (Lee et al., 2010).
Admittedly, ketamine could act on var-
ious neuronal and glial cell types and
my hypothesis seems to be plausible
for signals acting at very low concen-
trations such as neurotrophins, whereas
for glutamate, the main excitatory trans-
mitter of the central nervous system,
some supporting arguments are necessary.
Principally, upregulation of hippocampal
metabotropic glutamate receptor 5 has
been identified in temporal lobe epilepsy
(Notenboom et al., 2006). Importantly,
upregulations of other receptors in astro-
cytes have also been found in brains
with Alzheimer disease (Yu et al., 2012)
and with Parkinson disease. The increased
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expression of protease-activated receptors-
1 in astrocytes in substantia nigra pars
compacta of Parkinson disease brains is
the restorative move taken by the brain
to provide neuroprotection against neu-
ronal degeneration (Ishida et al., 2006).
Since upregulations of astrocytic receptors
occur in brains with neurodegenerative
diseases, upregulation of glutamatergic
receptors in astrocytes could also be found
in brains with major depression. However,
the mechanism proposed causing synaptic
imbalance is new and must be experimen-
tally verified.
The physiological and pathophysiolog-
ical considerations shortly discussed allow
the following hypothesis: supposing that
in therapy-resistant depression a signifi-
cant excess of NMDA receptors in astro-
cytes is causing a severe lack of glutamate
which cannot be balanced by reuptake
inhibitory drugs, the blockade of the excess
of NMDA receptors in astrocytes may
rapidly balance synaptic information pro-
cessing. Importantly, since all of the vari-
ous neurotransmitters and their receptors
in the neuronal and glial cell systems may
play a role in depression, my model of
depressionmight open a new dimension in
the development of antidepressants, espe-
cially what the treatment of patients with
a chronic depression concerns. It should
also be noted that this model is testable by
counting or quantifying astrocytic recep-
tors at least in postmortem brains.
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